BackNevro Overview

Nevro Receivables

Track Nevro's receivables ($72M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$71.88M
9.44% YoYΔ $-7.49M vs prior year quarter

Peer average

Loading

Nevro Receivables History

Loading

Nevro vs. peers: Receivables Comparison

Loading

Nevro Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nevro (NVRO) FAQ

As of the most recent data (December 2024), NVRO shows a receivables of $72M. That compares with $79M in the prior-year period — down 9.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVRO's receivables is now $72M (was $79M) — a 9.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Nevro is outperforming or lagging.

Tracking NVRO's receivables over time shows whether Nevro is scaling, shrinking, or reshaping that part of the business. The current reading is $72M That compares with $79M in the prior-year period — down 9.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Nevro's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $72M) with ownership activity and broader fundamentals.

Nevro's receivables is $72M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.